# Visit Capture Dia Clinical Readability — received independent A3 P2 review finding

Date: 2026-10-10. **Independent READ-ONLY handback supplied by Product Owner; author receipt, not a new independent verdict.**

Repository: `athpapachr-cmd/osteoporosis`. Draft PR [#143](https://github.com/athpapachr-cmd/osteoporosis/pull/143).
Independent reviewed implementation+test head: `a2c9fc09b0372b058e8f622b02a1cc20b6b87b1b`.
PR head at reviewer handback: `69be1fbdf085462313f4e1367902013ee5a15242` (only documentation after reviewed implementation).
Fresh production main on receipt: `987d5aef0e4191fbae436b3aa9df310db2a54a97`.

## Received finite verdict
**BLOCK / COMPLETE_FOR_DECLARED_SCOPE = NO / P0:P1:P2 = 0:0:1.**
- A1 Dia prompt/clinical source integrity: PASS.
- A2 Source-only structured presentation: PASS.
- A3 Explicit points for confirmation: BLOCK, one P2.
- A4 Protected patient state/Save: PASS.

## Source-proven P2
`readExplicitReviewNotes()` in `static/cockpit/visit-capture/app.js` stopped collecting notes for only a partial list of major headings; it did not stop at the subsequent `Ιστορικό:`, `Ευρήματα:` or `Φαρμακευτική αγωγή:` headings even though these are recognized in the source's `sectionNames` grammar. Thus bullets in later clinical sections were incorrectly shown as check items.

The independent reviewer supplied a synthetic example with one explicitly numbered note followed by History/Findings bullets; the old parser emitted three notes rather than one. This is misleading clinician UI, not patient recording, clinical diagnosis or a Save-authority change.

## Smallest authorized repair and review scope
Under PROCEDURES P5 the existing PR #143 writer applies a minimal stop-at-next-recognized-section fix, reusing the existing `sourceSectionHeading()` grammar; one synthetic Node regression demonstrates exactly one retained note, with History/Findings content still in the original source. A1/A2/A4, previous signed Visit Capture R2 and released PR #140 A4 remain CLOSED/REUSED.

Any tests on the corrected head are author evidence, not an independent closure. Exactly one fresh separate independent **A3 delta + affected cumulative** closure review is required before release. No other code, clinical source, backend, provider, merge, deploy or identifiable patient-data action.
